Bruker Corporation has emerged as the winner of an auction for NanoString Technologies and its spatial biology assets after the company filed for Chapter 11 bankruptcy earlier this year. The ...
Brad Gray talked to the Puget Sound Business Journal about how honing in on cancer diagnostics has already started to pay dividends. Seattle biotech NanoString Technologies (Nasdaq: NSTG) is finding ...
Bruker (NASDAQ:BRKR) will buy NanoString Technologies, a Seattle-based innovator in gene expression profiling and spatial transcriptomics for ~$392.6M in cash, and the assumption of certain ...
Bruker has formed a new, single division out of the various spatial biology assets it has acquired over the years. Now under a single operational banner, it includes the company’s previous Bruker ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed paper ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The acquisition marks the close ...
10x Genomics has begun commercial shipments of a new 5,000–plex gene expression panel that increases plex by an order of magnitude over previous panels, a month after announcing the launch of the ...
NanoString Technologies, Inc. announced the launch of a Single Cell Gene Expression application that provides researchers with a flexible and highly sensitive approach to discovering differences in ...
SEATTLE, April 10, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced ...
A company with roots in developing tools for translational research has raised $15.3 million to execute the first step of its pursuit of market share in diagnostics. When it was granted the CE Mark in ...
* Nanostring technologies-under terms of deal, lam will provide up to $50 million of funding intended to cover costs of development and regulatory approval * Nanostring technologies inc - lam will ...
NanoString Technologies (NSTG) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2022. This widely-known consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results